From Root Cause to Real Impact

A portfolio of RNA medicines for areas of urgent medical need.

The Engine Behind Every Program

01

A Platform that Translates Regulatory Genome Insights into RNA-Guided Medicines

Each program starts with deep understanding of the mechanistic drivers of disease grounded in the regulatory genome, enabling the creation of scientifically differentiated first-in-class RNA medicines with real patient impact.

Programs

02

Pipeline

Cardiac

Nonobstructive hypertrophy cardiomyopathy

ID PoC DC IND Ph1
Wisper/HTX-001

Pulmonary

Idiopathic pulmonary fibrosis & rejuvenation

ID PoC DC IND Ph1
Target undisclosed

Oncology

Solid tumors

ID PoC DC IND Ph1
Target undisclosed

New Discovery Programs

Other common & chronic diseases

ID PoC DC IND Ph1
Accelerated through strategic collaboration
Target undisclosed

Creating a New Paradigm in Drug Development

An accelerated path from target discovery to clinical validation powered by HAYA’s Engine.

Industry Standard
Year
0 1 2 3 4 5
ID
DC
Early clinical (PoM & PoC) EC*
HAYA Today
0 1 2 3 4 5
-2 Years
ID
DC
Early clinical (PoM & PoC) EC*
*Early clinical (PoM & PoC)

Our Strategic Focus

03

While HAYA’s Engine is versatile, our internal pipeline prioritizes fibrotic, metabolic, and age-related diseases, areas where causal, cell-state-directed medicines can shift the standard of care.


Our Promise

04

SANE Medicines for Complex Disease

Safe, Accessible, Needed, Effective


Partnerships & Investors

05

Partnering to Translate Causal Biology into Real-World Therapies

Get involved to learn more about our innovative platform and programs.